Dr. Sreejayan Nair, PhD, MPharm, FAHA, is professor of pharmacology, chair of the Division of Pharmaceutical Sciences, and director of the Biomedical Sciences PhD Program at the University of Wyoming, and also serves as the pharmacology thread lead for the WWAMI Medical School, overseeing integrated pharmacology education for medical students. He received his PhD from the College of Pharmaceutical Sciences, Manipal, India, and completed his postdoctoral training at the Department of Medicine II, Klinikum Grosshadern, Ludwig-Maximilians-Universität, Germany, and the Department of Physiology and Pharmacology, University of Tennessee Health Science Center, U.S. Dr. Nair has over 30 years of experience in pharmacology education, translational research, and mentorship, with his research focusing on protease biology and translational therapeutics for diabetes complications, cardiovascular disease, and neuroinflammation. He has led projects funded by the National Institutes of Health (NIH), the American Heart Association (AHA), and the American Diabetes Association (ADA), and has received multiple industry grants, supporting both basic discovery and translational applications. He has also authored over 100 peer-reviewed publications. A co-founder of two pharmaceutical start-ups, Dr. Nair holds patents in protease-targeted therapeutics, and has served as the principal investigator on NIH SBIR/STTR grants for bridging academic research and commercial innovation. He also serves as the mentoring director for the WY-NIH Sensory Biology COBRE, providing structured guidance to junior faculty. His teaching has been consistently recognized with honors such as the Ellbogen Meritorious Classroom Teaching Award and the Entrepreneur Award at the National IDeA Symposium of Biomedical Research Excellence. He has also contributed to the training of PhD, postdoctoral, graduate, and undergraduate students.
Dr. Nair’s Fulbright-Nehru project is integrating teaching and research to enhance pharmacology education and translational drug discovery at BITS Hyderabad. As part of the project, he is teaching a molecular pharmacology course, mentoring graduate students, and collaborating on molecular pharmacology/drug discovery projects related to diabetes complications and neuroinflammation. By combining classroom instruction with hands-on research and mentoring, the project aims to strengthen student training, support BITS’s PhD-IMPACT/DRIVE initiatives, and foster long-term Indo-U.S. collaborations in pharmacology and therapeutic innovation.